Francisco Quintana, PhD is a Professor of Neurology at the Ann Romney Center for Neurologic Diseases, at Brigham and Women’s Hospital, Harvard Medical School, and an Associate Member at the Broad Institute of Harvard and MIT. He is also the President of the International Society of Neuro Immunology (ISNI).

Dr. Quintana, a graduate of the University of Buenos Aires, obtained his PhD in immunology at the Weizmann Institute of Science. He received postdoctoral training at the Weizmann Institute of Science and Harvard Medical School, where he joined the faculty in 2009.

Dr. Quintana’s research is focused on Neuroimmunology, investigating signaling pathways that control inflammation and neurodegeneration, with the ultimate goal of identifying novel therapeutic targets and biomarkers for immune-mediated and neurodegenerative disorders. He has published over 200 peer reviewed articles and book chapters.  Dr. Quintana’s work identified an important role for the transcription factor AHR in the control of inflammation driven by adaptive and innate immune cells. His work has also defined novel mechanisms by which cell-cell interactions, metabolism, the microbiome, and environmental chemicals control CNS resident cells in health and disease. In addition, his research has resulted in multiple patents which have been the foundation of four companies.

Dr. Quintana is the recipient of many prestigious awards. He was most recently named the Kuchroo Weiner Distinguished Professor of Neuroimmunology in 2021.